Pollack MH, Otto MW, Roy-Byrne P, Coplan JD, Rothbaum BO, Simon NM, Gorman JM: Novel treatment approaches for refractory anxiety disorders. Depress Anxiety 2008; 25:467–76[Medline]Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB: Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30:208–225[Medline]
Stein MB, Goin MK, Pollack MH, Roy-Byrne P, Sareen J, Simon NM, Campbell-Sills L: American Psychiatric Association Work Group on Panic Disorder. Practice guideline for the treatment of patients with panic disorder,second edition. Am J Psychiatry (in press)
Batelaan N, de Graaf R, Van Balkom A, Vollebergh W, Beekman A: Thresholds for health and thresholds for illness: panic disorder versus subthreshold panic disorder. Psychol Med 2007; 37:247–56[Medline]
Boden JM, Fergusson DM, Horwood LJ: Anxiety disorders and suicidal behaviours in adolescence and young adulthood: findings from a longitudinal study. Psychol Med 2007; 37:431–440[Medline]
Connolly SD, Bernstein GA: Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007; 46:267–283[Medline]
Craske MG, Farchione TJ, Allen LB, Barrios V, Stoyanova M, Rose R: Cognitive behavioral therapy for panic disorder and comorbidity: more of the same or less of more? Behav Res Ther 2007; 45:1095–1109[Medline]
Etkin A, Wager TD: Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007; 164:1476–1488[Abstract/Free Full Text]
Furukawa TA, Watanabe N, Churchill R: Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev 2007:CD004364
Milrod B, Leon AC, Busch F, Rudden M, Schwalberg M, Clarkin J, Aronson A, Singer M, Turchin W, Klass ET, Graf E, Teres JJ, Shear MK: A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry 2007; 164:265–272[Abstract/Free Full Text]
Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B: A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depress Anxiety 2007; 24:1–14[Medline]
Siev J, Chambless DL: Specificity of treatment effects: cognitive therapy and relaxation for generalized anxiety and panic disorders. J Consult Clin Psychol 2007; 75:513–522[Medline]
Watanabe N, Churchill R, Furukawa TA: Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review. BMC Psychiatry 2007; 7:18[Medline]
Bystritsky A: Treatment-resistant anxiety disorders. Mol Psychiatry 2006; 11:805–814[Medline]
Carlbring P, Bohman S, Brunt S, Buhrman M, Westling BE, Ekselius L, Andersson G: Remote treatment of panic disorder: a randomized trial of internet-based cognitive behavior therapy supplemented with telephone calls. Am J Psychiatry 2006; 163:2119–2125[Abstract/Free Full Text]
Conway KP, Compton W, Stinson FS, Grant BF: Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006; 67:247–257[Medline]
Furukawa TA, Watanabe N, Churchill R: Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry 2006; 188:305–312[Abstract/Free Full Text]
Goodwin RD, Roy-Byrne P: Panic and suicidal ideation and suicide attempts: results from the National Comorbidity Survey. Depress Anxiety 2006; 23:124–132[Medline]
Heldt E, Gus Manfro G, Kipper L, Blaya C, Isolan L, Otto MW: One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission. Behav Res Ther 2006; 44:657–665[Medline]
Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters E: The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63:415–424[Abstract/Free Full Text]
Katon WJ: Clinical practice: panic disorder. N Engl J Med 2006; 354:2360–2367[Free Full Text]
Paulus MP, Stein, MB: An insular view of anxiety. Biol Psychiatry 2006; 60:383–387[Medline]
Ross, LE, McLean LM: Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry 2006; 67:1285–1298[Medline]
Roy-Byrne P, Craske M, Stein M: Panic disorder. Lancet 2006; 368:1023–1032[Medline]
Sareen J, Chartier M, Paulus MP, Stein MB: Illicit drug use and anxiety disorders: findings from two community surveys. Psychiatry Res 2006; 142:11–17[Medline]
Schraufnagel TJ, Wagner AW, Miranda J, Roy-Byrne PP: Treating minority patients with depression and anxiety: what does the evidence tell us. Gen Hosp Psychiatry 2006; 28:27–36[Medline]
Westra H, Dozois D: Preparing clients for cognitive behavior therapy: a randomized pilot study of motivational interviewing for anxiety. Cogn Ther Res 2006; 30:481–498
Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB: Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162:1179–1187[Abstract/Free Full Text]
Carlbring P, Nilsson-Ihrfelt E, Waara J, Kollenstam C, Buhrman M, Kaldo V, Söderberg M, Ekselius L, Andersson G: Treatment of panic disorder: live therapy vs. self-help via the Internet. Behav Res Ther 2005; 43:1321–1333[Medline]
Flint A: Anxiety and its disorders in late life: moving the field forward. Am J Geriatric Psychiatry 2005; 13:3–6[Medline]
Hettema JM, Prescott CA, Meyers JM, Neale MC, Kendler KS: The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 2005; 62:182–189[Abstract/Free Full Text]
Mitte K: A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord 2005; 88:27–45[Medline]
Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, Golinelli D, Sherbourne CD: A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 2005; 62:290–298[Abstract/Free Full Text]
Smoller JW, Yamaki LH, Fagerness JA, Biederman J, Racette S, Laird NM, Kagan J, Snidman N, Faraone SV, Hirshfeld-Becker D, Tsuang MT, Slaugenhaupt SA, Rosenbaum JF, Sklar PB: The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol Psychiatry 2005; 57:1485–1492[Medline]
Biederman J, Petty C, Faraone SV, Hirshfeld-Becker D, Pollack MH, Henin A, Gilbert J, Rosenbaum JF: Moderating effects of major depression on patterns of comorbidity in patients with panic disorder. Psychiatry Res 2004; 14:126,143–149
Deacon BJ, Abramowitz JS: Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings. J Clin Psychol 2004; 160:429–441
National Institute for Clinical Excellence: Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care.2004.http://www.nice.org.uk/CG022quickrefguide
Sheikh JI, Swales PJ, Carlson EB, Lindley SE: Aging and panic disorder: phenomenology, comorbidity, and risk factors. Am J Geriatr Psychiatry 2004; 12:102–109[Medline]
Fleet RP, Lavoie KL, Martel JP, Dupuis G, Marchand A, Beitman BD: Two-year follow-up status of emergency department patients with chest pain: was it panic disorder? CJEM 2003; 5:247–254[Medline]
Lewis-Fernandez R, Guarnaccia PJ, Martinez IE, Salman E, Schmidt A, Liebowitz M: Comparative phenomenology of ataques de nervios, panic attacks, and panic disorder. Cult Med Psychiatry 2002; 26:199–223[Medline]
Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D: Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry 2001; 58:681–686[Abstract/Free Full Text]
Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JR, Schneier FR, Stein MB, Helstad CP: Impact of generalized social anxiety disorder in managed care. Am J Psychiatry 2001; 158:1999–2007[Abstract/Free Full Text]
Fleet RP, Marchand A, Dupuis G, Kaczorowski J, Beitman BD: Comparing emergency department and psychiatric setting patients with panic disorder. Psychosomatics 1998; 39:512–518[Abstract/Free Full Text]
Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, Gorman JM, Papp LA: Multicenter collaborative Panic Disorder Severity Scale. Am J Psychiatry 1997; 154:1571–1575[Abstract/Free Full Text]
Nagy LM, Krystal JH, Woods SW, Charney DS: Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. Arch Gen Psychiatry 1989; 46:993–999[Abstract/Free Full Text]
Klein DF: Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 1964; 5:397–408[Medline]
Klein DF, Fink M: Psychiatric reaction patterns to imipramine. Am J Psychiatry 1962; 119:432–438[Abstract/Free Full Text]
Mörtberg E, Clark DM, Sundin O, Aberg Wistedt A. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial. Acta Psychiatr Scand 2007; 115:142–154[Medline]Sareen J, Campbell DW, Leslie WD, Malisza KL, Stein MB, Paulus MP, Kravetsky LB, Kjernisted KD, Walker JR, Reiss JP: Striatal function in generalized social phobia: a functional magnetic resonance imaging study. Biol Psychiatry 2007; 61:396–404[Medline]
Foa EB: Social anxiety disorder treatments: psychosocial therapies. J Clin Psychiatry 2006; 67(suppl 12):27–30
Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW: Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry 2006; 63:298–304[Abstract/Free Full Text]
Matthew SJ, Ho S: Etiology and neurobiology of social anxiety disorder. J Clin Psychiatry 2006; 67(suppl 12):9–13
Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME: Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry 2006; 59:424–429[Medline]
Stein MB: An epidemiologic perspective on social anxiety disorder. J Clin Psychiatry 2006; 67(suppl 12):3–8
Liebowitz MR, Mangano RM, Bradwejn J, Asnis G, SAD Study Group: A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. J Clin Psychiatry 2005; 66:238–247[Medline]
Mancini C, Van Ameringen M, Bennett M, Patterson B, Watson C: Emerging treatments for child and adolescent social phobia: a review. J Child Adolesc Psychopharmacol 2005; 15:589–607[Medline]
Bögels SM, Mansell W: Attention processes in the maintenance and treatment of social phobia: hypervigilance, avoidance and self-focused attention. Clin Psychol Rev. 2004; 24:827–856[Medline]
Van Ameringen M, Mancini C, Pipe B, Oakman J, Bennett M: An open trial of topiramate in the treatment of generalized social phobia. J Clin Psychiatry 2004; 65:1674–1678[Medline]
Heimberg RG: Cognitive-behavioral therapy for social anxiety disorder: current status and future directions. Biol Psychiatry 2002; 51:101–108[Medline]
Stein MB, Kean YM: Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry 2000; 157:1606–1613[Abstract/Free Full Text]
Liebowitz MR, Heimberg RG, Schneier FR, Hope DA, Davies S, Holt CS, Goetz D, Juster HR, Lin SH, Bruch MA, Marshall RD, Klein DF: Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depress Anxiety 1999; 10:89–98[Medline]
Kessler RC, Berglund P: Social phobia subtypes in the National Comorbidity Survey. Am J Psychiatry 1998; 155:613–619[Abstract/Free Full Text]
Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF: Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch Gen Psychiatry 1998; 55:1133–1141[Abstract/Free Full Text]
Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R: Phenelzine vs atenolol in social phobia; a placebo-controlled comparison. Arch Gen Psychiatry 1992; 49:290–300[Medline]
TOP
ABSTRACT
REFERENCES
